BLB&B Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.8M Sell
54,379
-391
-0.7% -$91.1K 0.51% 39
2026
Q1
$13.4M Sell
54,770
-3,713
-6% -$865K 0.55% 38
2025
Q4
$12.1M Sell
58,483
-671
-1% -$133K 0.51% 44
2025
Q3
$11M Sell
59,154
-1,775
-3% -$304K 0.47% 47
2025
Q2
$9.31M Sell
60,929
-4,941
-8% -$759K 0.43% 49
2025
Q1
$10.9M Sell
65,870
-3,237
-5% -$506K 0.56% 43
2024
Q4
$9.99M Sell
69,107
-6,324
-8% -$980K 0.51% 46
2024
Q3
$12.2M Sell
75,431
-11,645
-13% -$1.86M 0.62% 39
2024
Q2
$12.7M Sell
87,076
-42,580
-33% -$6.33M 0.7% 36
2024
Q1
$20.5M Sell
129,656
-465
-0.4% -$74K 1.16% 22
2023
Q4
$20.4M Buy
130,121
+446
+0.3% +$68.4K 1.29% 20
2023
Q3
$20.2M Buy
129,675
+2,165
+2% +$357K 1.44% 18
2023
Q2
$21.1M Sell
127,510
-524
-0.4% -$84.6K 1.48% 19
2023
Q1
$19.8M Sell
128,034
-1,078
-0.8% -$174K 1.48% 20
2022
Q4
$22.8M Sell
129,112
-2,432
-2% -$420K 1.77% 15
2022
Q3
$21.5M Buy
131,544
+736
+0.6% +$125K 1.79% 12
2022
Q2
$23.2M Sell
130,808
-515
-0.4% -$91.8K 1.84% 11
2022
Q1
$23.3M Buy
131,323
+486
+0.4% +$82.7K 1.56% 14
2021
Q4
$22.4M Sell
130,837
-20,049
-13% -$3.28M 1.45% 14
2021
Q3
$24.4M Buy
150,886
+19,236
+15% +$3.28M 1.63% 12
2021
Q2
$21.7M Buy
131,650
+869
+0.7% +$144K 1.57% 13
2021
Q1
$21.5M Sell
130,781
-19,964
-13% -$3.23M 1.69% 12
2020
Q4
$23.7M Buy
150,745
+21,428
+17% +$3.16M 1.92% 11
2020
Q3
$19.3M Buy
129,317
+1,125
+0.9% +$166K 1.93% 11
2020
Q2
$18M Sell
128,192
-344
-0.3% -$50.1K 1.95% 12
2020
Q1
$16.9M Sell
128,536
-1,352
-1% -$192K 2.2% 9
2019
Q4
$18.9M Sell
129,888
-2,792
-2% -$379K 1.97% 9
2019
Q3
$17.2M Sell
132,680
-2,278
-2% -$300K 1.93% 9
2019
Q2
$18.8M Sell
134,958
-420
-0.3% -$58.1K 2.16% 7
2019
Q1
$18.9M Buy
135,378
+5,570
+4% +$746K 2.23% 7
2018
Q4
$16.8M Sell
129,808
-2,529
-2% -$353K 2.3% 7
2018
Q3
$18.3M Buy
132,337
+3,695
+3% +$491K 2.28% 6
2018
Q2
$15.6M Sell
128,642
-3,850
-3% -$480K 2.12% 8
2018
Q1
$17M Buy
132,492
+5,402
+4% +$730K 2.27% 8
2017
Q4
$17.8M Sell
127,090
-664
-0.5% -$92.5K 2.54% 4
2017
Q3
$16.6M Buy
127,754
+1,020
+0.8% +$135K 2.56% 2
2017
Q2
$16.8M Sell
126,734
-674
-0.5% -$86K 2.78% 1
2017
Q1
$15.9M Sell
127,408
-2,305
-2% -$275K 2.7% 1
2016
Q4
$14.9M Buy
129,713
+401
+0.3% +$46.3K 2.6% 4
2016
Q3
$15.3M Sell
129,312
-153
-0.1% -$18.6K 2.78% 2
2016
Q2
$15.7M Sell
129,465
-225
-0.2% -$25.6K 2.96% 1
2016
Q1
$14M Buy
129,690
+7,688
+6% +$796K 2.82% 2
2015
Q4
$12.5M Sell
122,002
-610
-0.5% -$61.3K 2.65% 4
2015
Q3
$11.4M Buy
122,612
+3,871
+3% +$374K 2.54% 4
2015
Q2
$11.6M Buy
118,741
+6,947
+6% +$696K 2.4% 5
2015
Q1
$11.2M Buy
111,794
+4,262
+4% +$433K 2.34% 5
2014
Q4
$11.2M Sell
107,532
-375
-0.3% -$39.5K 2.38% 5
2014
Q3
$11.5M Buy
107,907
+110
+0.1% +$11.4K 2.49% 5
2014
Q2
$11.3M Buy
107,797
+2,021
+2% +$204K 2.41% 6
2014
Q1
$10.4M Buy
105,776
+576
+0.5% +$53.4K 2.29% 4
2013
Q4
$9.63M Buy
105,200
+435
+0.4% +$40.1K 2.31% 5
2013
Q3
$9.08M Buy
104,765
+56
+0.1% +$5.02K 2.39% 5
2013
Q2
$8.99M Buy
+104,709
New +$8.89M 2.5% 5

Other funds holding JNJ

BLB&B Advisors's JNJ Position: Q2 2026 in Review

BLB&B Advisors reduced its Johnson & Johnson (JNJ) stake by 0.71% in Q2 2026, selling an estimated $91.1K and leaving 54,379 shares worth $13.8M. The position accounts for 0.51% of the portfolio, ranked #39.

BLB&B Advisors first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. The position peaked at $24.4M in Q3 2021. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • BLB&B Advisors held 54,379 shares of Johnson & Johnson worth $13.8M as of Q2 2026.
  • BLB&B Advisors sold 391 Johnson & Johnson shares in Q2 2026, an estimated $91.1K.
  • Johnson & Johnson made up 0.51% of BLB&B Advisors's portfolio in Q2 2026, its #39 holding.
  • BLB&B Advisors first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • BLB&B Advisors's Johnson & Johnson position peaked at $24.4M in Q3 2021.
  • 4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on BLB&B Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.